Featured

10 min read

Owen Bray

10 min read

Owen Bray

The Prova Health Pulse is our latest roundup of what we’ve been working on, and the best of what’s caught our eye across the world of health innovation. In this issue: addressing adoption barriers for new drugs, evaluating LLMs in healthcare, building the future of UK health data and more.

10 min read

Owen Bray

Maximising pharma product launch success: How can pharmaceutical companies overcome systemic barriers to drug adoption? Featuring a case study in MASH

10 min read

Des Conroy

Maximising pharma product launch success: How can pharmaceutical companies overcome systemic barriers to drug adoption? Featuring a case study in MASH

10 min read

Des Conroy

Even the most groundbreaking drugs rarely reach their full commercial potential because of adoption friction: the structural and logistical realities that slow or limit their integration into health systems. Achieving a successful pharma product launch is difficult; 1 in 2 new drugs fail to meet launch forecasts. The emergence of the first treatments for MASH serves as a key case study, illustrating how diagnostic gaps, workforce shortages, and fragmented care create friction that leads to delayed or limited uptake. To maximise commercial success and ensure new products perform on launch expectations, companies must identify, characterise, and overcome the specific systemic barriers in key markets.

10 min read

Des Conroy

Recent Posts

Accelerate the adoption of your digital health solution